Julia Broussard
Pediatric Endocrinology · Kansas City, MONPI 1932393105
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 14 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 9 manufacturers, the largest accounting for just 21.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $424 and has fallen 56.1% since, to $186 in 2025.
Across 14 payments — averaging $53.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- BETA Bionics, Inc.$165
- Tandem Diabetes Care, Inc.$150
- Kyowa Kirin, Inc.$126
- Rhythm Pharmaceuticals, Inc.$115
- Sanofi-aventis U.S. LLC$107
- AbbVie$41
- plus $50 from 3 others
Across 10 payments — averaging $35,347 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$353K
What the payments were for
- Food & beverage$754100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| BETA Bionics, Inc. | 2 | $165 |
| Tandem Diabetes Care, Inc. | 5 | $150 |
| Kyowa Kirin, Inc. | 1 | $126 |
| Rhythm Pharmaceuticals, Inc. | 1 | $115 |
| Sanofi-aventis U.S. LLC | 1 | $107 |
| AbbVie | 1 | $41 |
| Neurocrine Biosciences, Inc. | 1 | $21 |
| Merck | 1 | $15 |
| Insulet Corporation | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$754 in reported general payments places this provider in the 70th percentile of 48 pediatric endocrinology providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 12 | $47 |
Paid to pharmacies, not to this prescriber.
Other pediatric endocrinology in Kansas City
- Ryan McDonoughKansas City$195K
- Joseph CernichKansas City$25K
- Matthew FeldtKansas City$13K
- Erica ZarseKansas City$3K
- Michelle KnollKansas City$940
- Figen UgrasbulKansas City$903
- Melissa Kaori LitaoKansas City$819
- Yun YanKansas City$651
- Cintya SchweisbergerKansas City$612
- Kavitha DileepanKansas City$504
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.